Links to professional and scholarly papers and reports submitted by members
Susie LagrataLong‐Term Outcomes of Occipital Nerve Stimulation for New Daily Persistent Headache With Migrainous Features
Susie Lagrata MSc Sanjay Cheema MBBS MRCP Laurence Watkins PhD Manjit Matharu PhD
Neuromodulation: Technology at the Neural Interface, 30-08-2020
Overview
This paper evaluates whether or not occipital nerve stimulation (ONS) is effective in the treatment of new daily persistent headache (NDPH) with migrainous features.
Maya Aquino-GuerreroFACEDOWN, LOCKDOWN, for a Virus that's Crowned! PICC Done!
Maya Aquino-Guerrero in collaboration with Dr Gillian Ray-Barruel
Alliance for Vascular Access Teaching and Research (AVATAR) Website, 04-05-2020
Overview
Guest blogger from the UK, Maya Guerrero, RN, VACNS (@CNS_IVnurse) presents her recent experience playing a peripherally inserted central catheter (PICC) in a Critical Care COVID19-positive patient in prone position, using ECG technology.
Maya Aquino-GuerreroAvoiding contamination of CVADs when bathing and showering
Nicola York, Nicki Angell-Barrick, Jo Carter, Maya Aquino-Guerrero
Journal of Kidney Care ,Vol. 5, No. 2,
30-03-2020
Overview
Delivery of dialysis through a tunnelled central venous access device (CVAD) is associated with a high risk of infection, when compared with other routes. The risk of contamination increases when the catheter dressing becomes wet, for example, when the patient is showering. Entry of the bacteria into the blood stream can result in a systemic infection. Protection pouches can be used to avoid this risk.
Susie LagrataNon-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania
Salwa Kamourieh, Susie Lagrata, Manjit Singh Matharu
Journal of Neurology, Neurosurgery and Psychiatry 90(9) Letters. October 2019
Overview
The authors' experience suggests that nVNS has potential use as a preventative therapy for PH in patients unable to tolerate indomethacin.
Susie LagrataMultiple cranial nerve blocks for the transitional treatment of chronic headaches
Sarah Miller, Susie Lagrata, Manjit Matharu
Cephalalgia. 39(12) pp1488-1499. 13 May 2019
Overview
Multiple cranial nerve blocks of the greater and lesser occipital, supraorbital, supratrochlear and auriculotemporal nerves are widely used in the treatment of primary headaches. The authors present efficacy and safety data for these procedures.
Maya Aquino-GuerreroClinical Review IV Film Dressings – Part 2 Securing Central Venous Access Devices (CVAD)
NHS Clinical Evaluation Team,
Maya Aquino-Guerrero (lead author)
NHS Supply Chain - Clinical and Product Assurance (CaPA), October 2018
Overview
This report focuses on dressings used to protect and secure Central Venous Access Devices (CVAD) in adults which are available to the NHS from the national procurement provider.
Maya Aquino-GuerreroClinical Review - Safety Peripheral Intravenous Cannula
NHS Clinical Evaluation Team,
Maya Aquino-Guerrero (lead author)
NHS Supply Chain - Clinical and Product Assurance (CaPA), October 2018
Overview
This report provides a clinical assessment of the usability and requirements from the NHS Safety Peripheral Intravenous Cannula or Catheter (SPIVC) that are available to the NHS from the national procurement provider.
Susie LagrataNurse-led OnabotulinumtoxinA (Botox®) clinic for chronic migraine
Susie M. Lagrata MSc and Manjit M. Matharu FRCP, PhD. Headache Group, Institute of NHNN
UCLH Connect Issue 4. December 2018
Overview
NHNN established a nurse-led Botox® clinic to meet the growing demand for the treatment. The nurse-led clinic is highly successful and offers a safe and cost-effective service. Results of the clinic’s audit show that it significantly improves the patient experience and increases patient satisfaction with their care.
NHNN established a nurse-led Botox® clinic to meet the growing demand for the treatment. The nurse-led clinic is highly successful and offers a safe and cost-effective service. Results of the clinic’s audit show that it significantly improves the patient experience and increases patient satisfaction with their care.
Maya Aquino-GuerreroClinical Review Intravenous Vapour Permeable Film Dressings (IV Films) – Part One Securing Peripheral Cannulae in Adults (CVAD)
NHS Clinical Evaluation Team,
Maya Aquino-Guerrero (lead author)
NHS Supply Chain - Clinical and Product Assurance (CaPA), March 2018
Overview
This report provides a clinical assessment of the usability and requirements from the NHS for Intravenous Vapour Permeable Film Dressings (IV film dressings).
Susie LagrataCutaneous Atrophy and Alopecia After Greater Occipital Nerve Injection Using Triamcinolone
Giorgio Lambru MD, Susie Lagrata BSc, Manjit S. Matharu FRCP, PhD
Headache: The Journal of Head and Face Pain, 52 (10) pp1596-1599. 18-10-2012
Overview
Reports the occurrence of cutaneous atrophy and alopecia in 4 patients who underwent GON blockade with triamcinolone and lidocaine.
Susie LagrataOptimal deep brain stimulation site and target connectivity for chronic cluster headache
Harith Akram, Sarah Miller, Susie Lagrata, Marwan Hariz, John Ashburner, Tim Behrens, Manjit Matharu, Ludvic Zrinzo
Neurology 89(20) pp2083-2091. 13 October 2018
Overview
This paper investigates the mechanism of action of deep brain stimulation for refractory chronic cluster headache and the optimal target within the ventral tegmental area.
This paper investigates the mechanism of action of deep brain stimulation for refractory chronic cluster headache and the optimal target within the ventral tegmental area.
Susie LagrataMicrovascular decompression or neuromodulation in patients with SUNCT and trigeminal neurovascular conflict?
Samih Hassan, Susie Lagrata, Andrew Levy, Manjit Matharu, Ludvic Zrinzo
Cephalalgia 38(2) pp393-398. 4 October 2017
Overview
This paper assesses the effectiveness of neuromodulation and trigeminal microvascular decompression (MVD) in patients with medically-intractable short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT).
This paper assesses the effectiveness of neuromodulation and trigeminal microvascular decompression (MVD) in patients with medically-intractable short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT).